Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
ReStart and Better Announce a Partnership to Improve Data Interoperability Within the NHS
ReStart and Better have signed a partnership agreement to improve interoperability between NHS organisations, regardless of […]
£64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery
Better health outcomes through more effective and efficient research as seen throughout the pandemic Promoting […]
Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive
Collaboration comes as all adults aged 18 and over invited to get a jab Filters […]
More than 30 Million People Vaccinated with Second Dose
More than 30 million people in the UK have been vaccinated with a second dose […]
£36 Million Boost for AI Technologies to Revolutionise NHS Care
New technology will help detect cancers and provide mental health support Projects are part of […]
Sir Richard Sykes Appointed Chair of Vaccine Taskforce
Sir Richard will use his extensive experience in biotechnology and pharmaceuticals to lead the significant […]
Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics
Life science industry leaders are joining forces with governments to step up collective efforts to […]
New UK Strategy Sets out Ambition to Be World Leaders in Organ Donation and Transplantation
Increasing consent rates for organ donation and making the most of donated organs for transplant […]
Eddie Gray Appointed Chair of Antivirals Taskforce
The UK government has appointed Eddie Gray as the new chair of the Antivirals Taskforce. […]
NHS Treats First Patient with the ‘World’s Most Expensive Drug’
A five-month old baby has become the first patient to receive a potentially life-saving drug […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more